PCR primers for detection of human GFRα-1 were designed to
span intron 6 according to the GFRα-1 gene sequence
(GenBank accession number: NM005264; GenBank is provided in the public
domain by the National Center for Biotechnology Information, Bethesda,
MD, and is available at http://www.ncbi.nlm.nih.gov/) so that the
amplification of potentially contaminating genomic DNA would produce
PCR fragments that were substantially larger than the cDNA PCR
products. The DNA sequences of forward and reverse primers are:
AGACCATCGTGCCTGTGTGCT (forward), and GGGTCATGACTGTGCCAATAAG (reverse),
with a resultant 216-bp product. First-strand cDNA was synthesized by
incubating 0.1 μg mRNA with 0.5 μg oligo d(T)primer, 200 U Moloney
murine leukemia virus (M-MLV) reverse transcriptase,
desoxyribonucleotides (dATP, dCTP, dGTP, and dTTP in a concentration of
0.5 mM) and recombinant RNasin RNase inhibitor (25 U) in 25 μl for
1.5 hours at 42°C. PCR was performed using 0.5 μl single-strand
cDNA with 3 U Thermus aquaticus DNA polymerase,
desoxyribonucleotides (concentration of 0.2 mM), PCR buffer, and 25
pmol upstream and downstream primers in 50 μl (all reagents from
Promega). A thermocycler (PTC-100; MJ Research, Watertown, MA) was used
at 95°C for 3 minutes (predenaturation). Then, 35 cycles were
performed including denaturation at 94°C for 1 minute, annealing at
55°C for 1 minute, and extension at 72°C for 1 minute. PCR products
were size fractionated by 2% agarose gel electrophoresis. We used Phi
X 174 DNA/HinfI fragments (Promega) as a molecular weight
standard. PCR fragments were cloned into pCR2.1 vectors (Invitrogen,
San Diego, CA) and sequences confirmed by standard methods.